Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07175909
NA

Proteomics Analysis of Human Tears in the Diagnosis and Management of Dry Eye Disease

Sponsor: The Hong Kong Polytechnic University

View on ClinicalTrials.gov

Summary

In this study, the initial tear proteome profiles in Dry Eye Disease (DED) patients, the safety and effectiveness of using an EC certificate DED treatment device in DED management, together with the associated global tear proteome changes, will be investigated.

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

75

Start Date

2021-01-01

Completion Date

2025-12-31

Last Updated

2025-09-16

Healthy Volunteers

No

Interventions

DEVICE

The Rexon-Eye, an electrotherapy device utilizing Quantum Molecular Resonance (QMR) technology

The device has received EC certification as a medical device for the treatment of ocular surface disorders. It will deliver a low-intensity alternating electrical current (ranging from 4 MHz to 64 MHz) to targeted biological tissue via contact electrodes. Previous studies have shown the effectiveness of this treatment in alleviating dry eye symptoms, both subjectively and objectively.

Locations (1)

The Hong Kong Polytechnic University, Hong Kong,

Hong Kong, Hong Kong